Loss-of-function genetic screening identifies a cluster of ribosomal proteins regulating p53 function

Carcinogenesis

Volumn 29, Issue 7, 2008, Pages 1343-1350

  Castro, Maria E ^a   Leal, Juan F M ^a   Lleonart, Matilde E ^b   Ramon y Cajal, Santiago ^a   Carnero, Amancio ^a  

^a Structural Biology and Biocomputing Programme   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; ENHANCED GREEN FLUORESCENT PROTEIN; MESSENGER RNA; NUCLEAR PROTEIN; PROTEIN L 12; PROTEIN L13; PROTEIN L19; PROTEIN L21; PROTEIN L23; PROTEIN L4; PROTEIN L5; PROTEIN L6; PROTEIN MDM2; PROTEIN P2; PROTEIN P21; PROTEIN P53; PROTEIN S 16; PROTEIN S 9; PROTEIN S20; PROTEIN S25; PROTEIN S6; RIBOSOME PROTEIN;

ANIMAL CELL; ARTICLE; CELL GROWTH; COLON TUMOR; CONTROLLED STUDY; DOWN REGULATION; GENE CLUSTER; GENETIC REGULATION; GENETIC SCREENING; HUMAN; HUMAN TISSUE; LUNG TUMOR; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE TUMOR; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RNA TRANSLATION; SENESCENCE;

ANIMALS; CELL GROWTH PROCESSES; CELL LINE; CELLS, CULTURED; EMBRYO, MAMMALIAN; FIBROBLASTS; MICE; MICE, KNOCKOUT; RIBOSOMAL PROTEINS; RNA, ANTISENSE; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 49349098765     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm302     Document Type: Article

References (45)

1. Hollstein,M. et al. (1994) Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res., 22, 3551-3555.
2. Lohrum,M.A. et al. (2000) Regulation and function of the p53-related proteins: Same family, different rules. Trends Cell Biol. 10, 197-202.
3. Steinmeyer,K. et al. (1990) Cell cycle control by p53 in normal (3T3) and chemically transformed (Meth A) mouse cells. I. Regulation of p53 expression. Oncogen, 5, 1691-1699.
4. Yonish-Rouach,E. et al. (1991) Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352, 345-347.
5. Serrano,M. et al. (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p161NK4a. Cell, 88, 593-602.
6. Jacks,T. et al. (1996) Cell-cycle control and its watchman. Nature, 381, 643-644.
7. Levin,A.J. (1997) p53, the cellular gatekeeper for growth and division. Cell, 88, 323-331.
8. Jeffrey,P.D. et al. (1995) Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms. Science, 267, 1498-1502.
9. el-Deiry,W.S. (199.8) Regulation of p53 downstream genes. Semin. Cancer Biol., 8, 345-357.
10. Lowe,S.W. et al. (1993) Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev. 7, 535-545.
11. Ferbeyre,G. et al. (2002) Oncogenic ras and p53 cooperate to induce cellular senescence. Mol. Cell. Biol., 22, 3497-3508.
12. Haupt,Y. et al. (1997) Mdm2 promotes the rapid degradation of p53. Nature, 387, 296-299.
13. Kubbutat,M.H. et al. (1997) Regulation of p53 stability by Mdm2. Nature, 387, 299-303.
14. Tao,W. et al. (1999) Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53. Proc. Natl Acad. Sci. USA, 96, 3077-3080.
15. Weber,J.D. et al. (1999) Nucleolar Arf sequesters Mdm2 and activates p53. Nat. Cell Biol., 1, 20-26.
16. Lohrum,M.A. et al. (2000) Contribution of two independent MDM2-binding domains in p14(ARF) to p53 stabilization. Curr. Biol. 10, 539-542.
17. Gilkes,D.M. et al. (2006) MDMX regulation of p53 response to ribosomal stress. EMBO J., 25, 5614-5625.
18. Castro,M.E. et al. (2004) Cellular senescence induced by p53-ras cooperation is independent of p21waf1 in murine embryo fibroblasts. J. Cell. Biochem., 92, 514-524.
19. Castro,M. E. et al. (2007) PPP1CA contributes to the senescence program induced by oncogenic Ras. Carcinogenesis in press.
20. Conlon,I. et al. (1999) Size control in animal development. Cell, 96, 235-244.
21. Neufeld,T.P. et al. (1998) Connections between growth and the cell cycle. Curr. Opin. Cell Biol., 10, 784-790.
22. Warner,J.R. (1999) The economics of ribosome biosynthesis in yeast. Trends Biochem. Sci., 24, 437-440.
23. Kressler,D. et al. (1999) Protein trans-acting factors involved in ribosome biogenesis in Saccharomyces cerevisiae. Mol. Cell. Biol., 19, 7897-7912.
24. Venema,J. et al. (1999) Ribosome synthesis in Saccharomyces cerevisiae. Annu. Rev. Genet., 33, 261-311.
25. Carnero,A. et al. (2000) Loss-of-function genetics in mammalian cells: The p53 tumor suppressor model. Nucleic Acids Res., 28 2234-2241.
26. Dai,M.S. et al. (2004) Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol. Cell. Biol., 24, 7654-7668.
27. Dai,M.S. et al. (2004) Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J. Biol. Chem., 279, 44475-44482.
28. Dai,M.S. et al. (2006) Regulation of the MDM2-p53 pathway by ribosomal protein L11 involves a post-ubiquitination mechanism. J. Biol. Chem., 281, 24304-24313.
29. Oren,M. (2003) Decision making by p53: Life, death and cancer. Cell Death Differ., 10, 431-442.
30. Zhang,Y. et al. (2003) Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol. Cell. Biol., 23, 8902-8912.
31. Takagi,M. et al. (2005) Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell, 123, 49-63.
32. Chen,L. et al. (2005) ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage. EMBO J., 24 3411-3422.
33. Chen,D. et al. (2005) ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor. Cell, 121, 1071-1083.
34. Gilkes,D.M. et al. (2007) Distinct roles of MDMX in the regulation of p53 response to ribosomal stress. Cell Cycle, 6, 151-155.
35. Pestov,D.G. et al. (2001) Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: Effects of nucleolar protein Bop1 on G(1)/S transition. Mol. Cell. Biol., 21, 4246-4255.
36. Ashcroft,M. et al. (1999) Regulation of p53 function and stability by phosphorylation. Mol. Cell. Biol., 19, 1751-1758.
37. Ashcroft,M. et al. (2000) Stress signals utilize multiple pathways to stabilize p53. Mol. Cell. Biol., 20, 3224-3233.
38. Lohrum,M.A. et al. (2003) Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell, 3, 577-587.
39. Jin,A. et al. (2004) Inhibition of HDM2 and activation of p53 by ribosomal protein L23. Mol. Cell. Biol., 24, 7669-7680.
40. Leng,R.P. et al. (2003) Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell, 112, 779-791.
41. Toledo,F. et al. (2006) Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat. Rev. Cancer, 6, 909-923.
42. Amsterdam,A. et al. (2004) Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol., 2, E139.
43. Beck-Engeser,G.B. et al. (2001) Point mutation in essential genes with loss or mutation of the second allele: Relevance to the retention of tumor-specific antigens. J. Exp. Med., 194, 285-300.
44. Draptchinskaia,N. et al. (1999) The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat. Genet., 21, 169-175.
45. Ruggero,D. et al. (2003) Does the ribosome translate cancer? Nat. Rev. Cancer, 3, 179-192.